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Abstract
Background: Hospitalisations are the prime contributor to healthcare expenditure, with older adults often
identified as high hospital users. Despite the apparent high use of hospitals at the end of life, limited evidence
currently exists regarding reasons for hospitalisation. Understanding complex end of life care needs is required for
future health care planning as the global population ages. This study aimed to investigate patterns of
hospitalisation in the last year of life by cause of death (COD) as well as reasons for admission and short-term
predictors of hospital use.
Methods: Survey data from 1,205 decedents from the 1921–1926 cohort of the Australian Longitudinal Study on
Women’s Health were matched with the state-based hospital records and the National Death Index. Hospital
patterns based on COD were graphically summarised and multivariate logistic regression models examined the
impact of short-term predictors of length of stay (LOS).
Results: 85 % of women had at least one admission in the last year of life; and 8 % had their first observed
admission during this time. Reasons for hospitalisation, timing of admissions and LOS differed by COD. Women
who died of cancer, diabetes and ‘other’ causes were admitted earlier than women who died of organ failure,
dementia and influenza. Women who died of organ failure overall spent the longest time in hospital, and women
with cancer had the highest median LOS. Longer LOS was associated with previous short- and medium-term-
hospitalisations and type of hospital separation.
Conclusions: Reducing acute care admissions and LOS at the end of life is complex and requires a shift in
perceptions and treatment regarding end of life care and chronic disease management.
Keywords: Women, Old age, Hospital, Admissions, End of life, Chronic disease
Abbreviations: ALSWH, Australian longitudinal study on women’s health; APDC, Admitted patients data collection;
COD, Cause of death; GPs, General practitioners; LOS, Length of stay; NDI, National death index; NSW, New South Wales
Background
Population ageing is expected to have widespread global
implications for healthcare delivery and expenditure. In
2013, 841 million of the world’s population was aged over
60 years. It is projected that this figure will increase
exponentially to two billion by 2050 [1]. In Australia, the
proportion of adults aged over 65 has risen by
approximately 30 % in the last decade. Ageing and health
pressures are projected to result in a 24 % increase in
government expenditure for health by 2055 [2]. This
upward trend is projected across a number of other
industrialised countries [3].
Hospitalisations have been identified as a prime
contributor to healthcare expenditure, with older adults
often identified as high hospital users [4, 5]. Proponents
of the compression of morbidity hypothesis [6, 7] have
focused on the disproportionate use of healthcare
services towards the end of life, arguing that increased
hospital use is associated with proximity to death rather
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than chronological age [8]. Menec and colleagues [9]
found that 79 % of rural Canadian decedents were
admitted to hospital at least once within the 6 months
prior to death and around 60 % died while in hospital.
Menec et al. [10] also found that 37 % of hospital use
was concentrated into the last month prior to death,
while an Australian study found a marked increase in
admissions in the last 108 days for cancer-related deaths
and 83 days for non-cancer related deaths [11].
Despite the apparent high use of hospitals at the end
of life, examination of hospitalisation trajectories and
reasons for hospitalisation using longitudinal population
representative data across a number of causes of death is
required. A recent retrospective chart study involving
Dutch out-of-hours general practitioners (GPs) found
that palliative care patients (identified by the terms such
as palliative, terminal, and cancer) were most often
hospitalised for the control of digestive, endocrine,
metabolic and nutritional and respiratory symptoms
[12]. Hospital admission was however dependent upon a
number of factors including disease type, with cancer
and cardiovascular cases more likely to be hospitalised.
A follow-up GP-focused study comparing overnight hos-
pitalisations in the 3 months prior to death for cancer
and non-cancer patients found that while 71 different
reasons were reported for the last hospitalisation, these
differed according to death trajectory [13]. Cancer
patients were most often admitted for the control of
digestive symptoms and pain, while non-cancer patients
were admitted for respiratory symptom control and
cardiovascular complaints. Cancer patients were signifi-
cantly more likely to have a shorter stay in hospital
(<3 days) at their last admission and were less likely to
die in hospital. Meanwhile, non-cancer patients were
more likely to have multimorbidity and curative treat-
ment as the goal prior to their last hospitalisation.
Previous cross-sectional and short-term follow-up
studies have demonstrated that a number of patient-
specific factors impact on the end of life care for older
adults. In studies from the United States and Europe,
age has been found to be associated with number of bed
days and treatment decisions [10, 14]. Previous research
has also demonstrated that functional capacity is a
powerful predictor of high morbidity and mortality, par-
ticularly among hospitalised older adults [15, 16] and
has been associated with end of life expenditure [17].
Kelley et al. [18] found that declines in functional cap-
acity and increasing activities of daily living dependency
were associated with increased number of bed days in
the last 6 months of life. Lunney et al. [19] on the other
hand found that functional decline fluctuates in the last
year of life and is highly dependent of the type of disease
trajectory, with marked differences noted for those with
cancer, organ failure and frailty-related trajectories.
When focused on death in hospital, increased associa-
tions have been found for living alone, presence of
certain chronic diseases, ethnicity, rural residence, and
fewer social contacts [9, 20, 21].
Improving end of life care is a global public health
priority [22]. Understanding complex end of life care
needs is required for future health care planning as the
global population ages. However, previous research has
largely focused on palliative care samples or specific
community sub-populations, short observation periods
and proxy recall. Understanding the reasons for hospital-
isation and factors associated with hospitalisation re-
quires examination of representative population level
data across the spectrum of old age, including the very
old (who are often excluded from research). This study
aims to fill this gap by describing patterns of hospitalisa-
tion in the last year of life according to cause of death
(COD) for older Australian women using data collected
over a 12 year period. Reasons for hospitalisation and
short-term predictors of hospital use are also explored.
Method
Overview of study design and participants
This study used data from the 1921–1926 cohort of the
Australian Longitudinal Study on Women’s Health
(ALSWH). Baseline surveys were completed in 1996
when the women were aged 70–75 years (N = 12,432).
The cohort has been surveyed every 3 years since
1996. Participants were eligible for the study if they
were New South Wales (NSW) residents and died
between July, 2001 and June, 2013 (N = 1,205/4,363).
Deaths records were obtained from the National
Death Index (NDI) [23] and were matched on identi-
fying information including name, address, gender,
state, and date of birth.
Measures
COD
Participants were classified into one of six groups based
on primary COD in the NDI and using ICD-10 principle
diagnosis codes. Similar to previous research [19, 24],
the following conditions were included: cancer (ICD-10
codes C00-C997, D37, D44.0-D48.7), organ (i.e. heart,
lung, kidney and liver) failure (ICD-10 codes I255.5, I42,
I50-I51, J43-J44, J47, J61, J84, N18, K74), and Alzheimer’s
disease/dementia (ICD-10 codes F03, R54, A81, F01, F03,
G30). As diabetes (ICD-10 codes E10-E14) and influenza/
pneumonia (ICD-10 codes J09-J18) also represent leading
causes of death in this age group in Australia [25] and are
associated with differing levels of disability [26], they were
included as separate groups. All remaining causes of death
were classified as ‘other’.
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Hospital admissions
Hospital care in Australia is provided by a tax-funded
universal healthcare system which receives funding at
national and state levels and is managed separately by
each state or territory. Data on admissions to hospital
(bed days) in the 12 months prior to death (for each
participant) were collected from the NSW Admitted
Patients Data Collection (APDC). This database contains
hospital inpatient information from public and private
hospitals including admission and separation dates, and
reason for admission (based on ICD-10 codes) [27].
Length of stay (LOS)
Women’s maximum admission length in the last year of
life was categorised into one of three exclusive categor-
ies: (i) >0 and ≤5.8 days (acute LOS); (ii) >5.8 and
≤11.9 days (medium LOS); and (iii) >11.9 days (palliative
LOS) based on the average length of stay for overnight
separations and palliative admissions [28].
Explanatory variables
Age at death was calculated from two strongly correlated
datasets: the APDC (if the participant died in hospital)
or alternatively the ALSWH dataset (using NDI data).
Baseline predisposing characteristics for each COD cat-
egory were measured using data from the ALSWH 1996
survey. These included highest educational qualification,
Country of birth, language spoken at home, smoking sta-
tus [29], alcohol consumption and area of residence [30].
The following variables were included in the multivari-
ate model examining short-term predictors of hospital-
isation. Unless stated otherwise, variables were taken
from the survey closest to the participant’s date of death.
This included marital status, contributing to private
health insurance, physical functioning and falls experi-
enced in the previous 12 months. History of hyperten-
sion, arthritis and asthma were determined firstly from
the COD ICD-10 codes. Missing data was filled in using
either APDC hospital admission data (ICD-10 principle
diagnoses) or ALSWH self-report (doctor diagnosis).
Mode of separation was determined from the APDC and
derived from the last hospital admission prior to death
(home, death in hospital, nursing home).
Ethical approval
The ALSWH project has ongoing ethical clearance from
both the University of Newcastle and University of Queens-
land’s Human Research Ethics Committees. Ethical ap-
proval for the linkage of ALSWH survey data to the NSW
APDC was received from the NSW Population and Health
Services Research Ethics Committee, while linkage to the
NDI was approved by the AIHW Ethics Committee. All
participants provided informed consent for completion of
the self-report survey and linkage to administrative data.
Statistical analysis
Descriptive statistics were used to examine baseline and
hospital characteristics for each of the COD groups. Pat-
terns of hospital use over the 12 months prior to death
and cumulative LOS days for each COD were graphically
summarised. Three separate logistic regression models
were constructed using backward elimination techniques
to examine the impact of predisposing and health-related
factors on LOS categories. Predictor variables entered into
the multivariate analysis were chosen using a conservative
significance level (p < 0.25). Due to the oversampling of
participants from rural and remote areas, all models
controlled for area of residence. The acute LOS model
(comparing women categorised as having an ‘acute stay’
with those with no hospitalisation in the last year of life)
also included age at death, time from last survey, mode of
separation at last admission, marital status, contribution
to private health insurance, COD, chronic conditions,
physical functioning and falls. The medium LOS model
(comparing women categorised as having a ‘medium stay’
to those women included in the acute LOS analysis [i.e.
acute LOS and no hospitalisation]) included all variables
from the acute LOS model with addition of number of
acute length hospitalisations. The palliative LOS model
(comparing women categorised as having a ‘palliative stay’
to those women included in the medium LOS analysis
[i.e. medium LOS, acute LOS and no hospitalisation])
included all variables from the medium LOS model
with the addition of number of medium length hospi-
talisations. The Hosmer and Lemeshow goodness-of-fit
test was used to assess the fit for each model, with odds
ratios (95 % Confidence Interval). Participants’ pre- and
post-survey information was used to fill in missing data
for predictor variables. The logistic regression analyses
were performed using STATA v13 (Stata Corporation,
College Station, TX). All other analyses were performed
using SAS v9.4 (x64).
Results
COD profile
Among the 1,205 women who died during the obser-
vation period, 30.5 % (n = 382) of deaths were attrib-
uted to cancer, 21.7 % (n = 270) to organ failure,
13.1 % (n = 138) to dementia/Alzheimer’s disease,
7.0 % (n = 81) to diabetes and 3.7 % (n = 51) to influ-
enza/pneumonia. The remaining 24.0 % (n = 283) were
attributed to other causes such as acute myocardial in-
farction (I21.9), stroke (I64), other chronic heart and
cerebrovascular disease (I25.9 and I69.8) and intracere-
bral hemorrhage (I61.9).
Baseline characteristics according to COD
Baseline characteristics according to each COD ICD code
are shown in Table 1. Compared to the other groups, a
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greater proportion of women died before the age of 80
when the COD was related to diabetes. Women with
dementia/Alzheimer’s disease as the primary COD were
most likely to have lived into very old age (44.5 %). In
addition to age at death, predisposing baseline characteris-
tics, smoking status, language spoken at home, and
alcohol consumption were significantly associated with
COD. Women who died of cancer were less likely to speak
English as a second language (69.0 %) and more likely to
be current smokers (13.3 %) compared to women in the
other groups (with the exception of influenza). Women
who died of diabetes-related causes were more likely to be
non-drinkers (56.2 %), while those with influenza were
more likely to be low risk drinkers (65.8 %) compared to
other women.
Hospital use in the last year of life
In all, 85 % of women had at least one hospital admis-
sion in the 12 months prior to death; and 8 % had their
first observed admission during this final 12 months.
There were significant differences between the 15 % of
women not hospitalised compared to the 85 % that had
at least one hospitalisation in the last year of life.
Women who did not have a hospitalisation were less
likely to be widowed (49 % vs 54.7 %), more likely to
have died of causes other than the five conditions of
interest (37 % vs 21 %) and more likely to have private
health insurance (100 % vs 55 %).
The top ten medical reasons for hospitalisation (based
on Australian Refined Diagnosis Related Groups) differed
according to COD (see Additional file 1: Table S1).
Although all groups of women were admitted at least once
for rehabilitative purposes during this period, the greatest
proportion of rehabilitation admissions were for women
who died of influenza/pneumonia (15.7 %), organ failure
(12.6 %) and ‘other’ causes (12.0 %). Women with influ-
enza/pneumonia as their primary COD were also likely to
be admitted for respiratory infection and inflammation
(33.3 %), stroke and other cerebrovascular disorders
(17.7 %) and other factors influencing health status
Table 1 Baseline characteristics by cause of death for women from the 1921–1926 cohort residing in NSW who died during the
period July 2001 and June 2013
Other
N (%)
Cancer
N (%)
Organ Failure
N (%)
Dementia/Alzheimer’s
N (%)
Diabetes
N (%)
Influenza/Pneumonia
N (%)
p-value
Area of residence
Metropolitan 117 (69.5) 140 (65.8) 98 (65.1) 68 (74.3) 35 (71.7) 15 (58.1) 0.238
Inner regional 120 (22.5) 180 (24.1) 116 (24.1) 49 (18.4) 27 (17.0) 31 (36.5)
Outer regional/
remote/very remote
46 (8.0) 62 (10.8) 56 (10.8) 21 (7.3) 19 (11.2) 5 (5.4)
Predisposing factors
aAverage age of death 82.2 (3.5) 82.6 (3.4) 83.2 (3.7) 84.5 (3.2) 85.5 (3.9) 82.6 (3.5)
Age at death
Up to 79 87 (30.8) 94 (24.8) 60 (22.8) 13 (9.6)* 26 (32.7) 13 (28.1) <0.0001
80–84 years 122 (40.3) 190 (49.5) 115 (43.1) 61 (45.9) 29 (36.2) 24 (45.6)
85+ years 74 (29.0) 98 (25.6) 95 (34.2) 64 (44.5)* 26 (31.2) 14 (26.4)
Highest qualifications
No formal/year 10 212 (78.3) 284 (77.2) 199 (75.4) 102 (79.0) 67 (88.6) 36 (72.6) 0.223
Post school 49 (21.7) 78 (22.8) 51 (24.6) 8 (21.0) 8 (11.4) 13 (27.4)
Country of birth 214 (71.9) 280 (68.4) 210 (72.6) 112 (79.2) 64 (78.4) 40 (74.1) 0.142
English as a second language 199 (76.0) 264 (69.0) 197 (74.0) 104 (81.5) 60 (81.3) 37 (78.1) 0.039
Smoking status
Non-smoker 156 (56.6) 205 (59.0) 128 (53.0) 73 (55.3) 54 (71.8) 29 (57.3) 0.032
Ex-smoker 82 (34.5) 109 (27.7) 85 (34.2) 46 (36.3) 16 (25.9) 12 (25.7)
Current smoker 25 (8.9) 49 (13.3) 38 (12.9) 10 (8.4) 1 (2.4) 7 (17.0)
Alcohol consumption
Non-drinker 98 (37.7) 125 (38.4) 95 (36.8) 44 (35.2) 37 (56.2)* 15 (30.9) 0.094
Low risk drinker 153 (58.8) 209 (56.7) 142 (58.2) 78 (57.2) 30 (42.5) 31 (65.8)*
Medium/risky drinker 9 (3.5) 20 (5.0) 15 (5.0) 8 (7.6) 2 (1.3) 3 (3.3)
ameans and standard deviations are reported
*Greatest cell contribution to the χ2-test
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(13.7 %). In addition to rehabilitative admissions, women
who died of dementia/Alzheimer’s disease or ‘other’ causes
were also likely to be admitted for stroke and other cere-
brovascular disorders (10.1 % and 9.1 % respectively).
Women with cancer as their primary COD were most
often admitted for digestive disorders (7.3 %), respiratory
infections (6.5 %) and post-surgery follow-up care (6.3 %).
Women who died of organ failure had the highest pro-
portion of admissions for chronic obstructive airway
disorders (18.5 %) of all groups and were commonly
admitted for heart failure and shock (16.7 %). Women
who died of diabetes had the highest proportion of admis-
sions for heart failure and shock (18.5 %) and circulatory
disorders (18.5 %).
Timing of admission to hospital in the last year of life
is shown in Fig. 1. Using the proportion at which 50 %
of women had been admitted at least once as an indica-
tor, women who died of cancer, diabetes and ‘other’
causes were admitted earlier with 50 % of women in
these groups admitted by the fifth month prior to death.
In contrast, women who died of organ failure, dementia
and influenza/pneumonia took until the second and
third month prior to death to reach the 50 % admission
rate. As shown in Table 2, a similar pattern was found in
terms of hospital use and proximity to death, with
71.4 % of women with influenza/pneumonia, and 63.6 %
of women with diabetes dying within 1 month of their
last admission, respectively.
The median cumulative LOS days for women in their last
year of life according to their primary COD is shown in
Fig. 2. No significant difference was found across the
groups in terms of days in hospital within 274–365 days
prior to death. Women who died of cancer had the highest
median number of bed days (Median = 23), followed by dia-
betes (Median = 16), organ failure (Median = 16), influenza/
pneumonia (Median = 13), ‘other’ (Median = 11) and de-
mentia/Alzheimer’s disease (Median = 10). The greatest in-
crease in average cumulative LOS days was seen within the
last 30 days prior to death for women with a primary COD
of cancer (13.9 days) compared to women with organ fail-
ure (11.2 days) or influenza (10.1 days). All other COD cat-
egories had an average increased stay of less than 10 days
within the last 30 days prior to death. Differences were
found for COD groups within 1 month of death
(Kruskal-Wallis test = 38.4, p-value <0.0001).
Death in hospital status, ability to live independently
and the days from last admission to death are shown in
Table 2. Importantly, around 60 % of women who died of
cancer and organ failure died in hospital, while 71.4 % of
women with influenza/pneumonia, and 63.6 % of women
with diabetes died within 1 month of their last admission.
Predictors of acute, medium and palliative lengths of stay
The proportion of women in each of the COD categories
who had a maximum LOS that was classified as either
acute, medium or palliative, as well as those who were
not admitted to hospital in their last year of life are also
shown in Table 2. Women who died of influenza/pneu-
monia were less likely to be admitted to hospital in the
last year of life. Women who died of diabetes (22.2 %)
were more likely to be admitted for an acute LOS, while
those with dementia were more likely to be admitted for
A) B) C)
D) E) F)
Fig. 1 Timing of overnight hospital admissions in the 12 months prior to death for women from the 1921–1926 cohort for the six specific causes of
death. The dashed line shows when 50 % of women for each specific cause of death had been admitted to hospital at least once in the last year of life
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Table 2 Hospital characteristics by cause of death for women from the 1921–1926 cohort
Other
N (%)
Cancer
N (%)
Organ Failure
N (%)
Dementia/Alzheimer’s
N (%)
Diabetes
N (%)
Influenza/Pneumonia
N (%)
p-value
Death in hospital
Yes 138 (49.5) 223 (59.4) 162 (59.2) 44 (29.5) 37 (44.9) 28 (55.5) <0.0001
No 81 (27.6) 123 (31.0) 84 (32.4) 67 (51.8) 32 (37.9) 13 (25.3)
Unknowna 64 (22.9) 36 (9.6) 24 (8.4) 27 (18.7) 12 (17.2) 10 (19.2)
Independent livingb 92 (33.3) 121 (32.1) 85 (31.6) 44 (32.1) 29 (36.3) 19 (38.0) 0.928
Days from last admission to death
< 1 week 95 (34.7) 132 (32.3) 102 (34.5) 27 (19.5) 24 (31.5) 21 (39.5) <0.0001
≥1 week <1 month 67 (22.2) 113 (29.3) 79 (28.7) 42 (32.1) 20 (32.1) 14 (31.9)
≥ 1 month <3 months 31 (11.5) 63 (19.3) 24 (10.7) 19 (14.6) 11 (11.1) 2 (2.2)
≥ 3 months < 1 year 26 (8.7) 38 (9.5) 41 (17.7) 23 (15.1) 14 (18.4) 4 (7.1)
No admissions 64 (22.9) 36 (9.6) 24 (8.4) 27 (18.7) 12 (17.2) 10 (19.2)
Hospital stay
No hospitalisation 10 (19.6) 36 (9.4)f 24 (8.9)f 27 (19.6) 12 (14.8) 64 (22.6)f <0.001
cAcute 10 (19.6) 58 (15.2) 51 (18.9) 30 (21.7) 18 (22.2) 56 (19.8)
dMedium 9 (17.7) 80 (20.9) 62 (23.0) 33 (23.9) 14 (17.3) 50 (17.7)
ePalliative 22 (43.1) 208 (54.5) 133 (49.3) 48 (34.8) 37 (45.7) 113 (39.9)
anot hospitalised
bmeasured from the ALSWH survey closest to death
can acute LOS was defined as >0 and ≤5.8 days
da medium LOS was defined as >5.8 and ≤11.9 days
ea palliative LOS was defined as >11.9 days
fGreatest cell contribution to the χ2-test
Fig. 2 Median cumulative overnight length of stay days in the 12 months prior to death for women from the 1921–1926 cohort
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a medium level LOS (23.9 %). Women who died of
cancer (54.5 %) and organ failure (49.3) were more likely
to have been admitted for a palliative level LOS.
Multivariable predictors of LOS are shown in Table 3.
The final reduced acute LOS model shows that women
who had been diagnosed or treated for arthritis were
72 % more likely to be hospitalised for an acute stay than
women without arthritis (95 % CI:1.08,2.72). When
COD was regressed onto LOS, women who died of
dementia/Alzheimer’s disease and ‘other’ causes were
approximately 40 % less likely than women who died of
cancer to be admitted for an acute LOS.
When medium levels of stay were examined, significant
associations were found for mode of separation, number of
Table 3 Predictors of acute, medium and palliative level length of stay (LOS) for women from the 1921–1926 cohort
Predictors Acute LOSa
N = 396
Medium LOSc
N = 644
Palliative LOSe
N = 1,205
Full model
OR (95 % CI)
Reduced modelb
OR (95 % CI)
Full model
OR (95 % CI)
Reduced modeld
OR (95 % CI)
Full model
OR (95 % CI)
Reduced modelf
OR (95 % CI)
Age at death 1.11 (1.05, 1.18)* 1.11 (1.04, 1.17)* 1.04 (0.99, 1.10)
Time from last survey to death (days) 1.00 (1.00, 1.00) 1.00 (0.99, 1.00)
Mode of separation from last admission
Home Reference Reference Reference Reference
Died in hospital 3.99 (2.70, 5.92)* 4.16 (2.87, 6.02)* 2.09 (1.57, 2.78)* 2.76 (2.11, 3.62)*
Nursing home 2.83 (1.43, 5.58)* 3.07 (1.57, 6.00)* 3.04 (1.93, 4.79)* 3.86 (2.49, 5.99)*
gWidowed marital status 0.79 (0.52, 1.22) 1.16 (0.90, 1.51) 1.21 (0.95, 1.55)
gPrivate health insurance 0.93 (0.71, 1.21)
hNumber of acute level
hospital admission
0.99 (0.85, 1.16) 0.98 (0.89, 1.08)
iNumber of medium level
hospital admissions
1.16 (1.01, 1.34)* 1.27 (1.10, 1.45)*
Cause of death
Cancer Reference Reference Reference Reference Reference Reference
Other 0.58 (0.33, 1.03) 0.60 (0.34, 1.06)* 0.54 (0.33, 0.88)* 0.53 (0.33, 0.86)* 0.66 (0.47, 0.94)* 0.61 (0.44, 0.86)*
Organ failure 1.15 (0.59, 2.24) 1.18 (0.61, 2.29) 0.81 (0.49, 1.33) 0.83 (0.51, 1.37) 0.83 (0.58, 1.18) 0.76 (0.54, 1.06)
Dementia/Alzheimer’s disease 0.60 (0.29, 1.21) 0.62 (0.31, 1.25)* 0.80 (0.44, 1.45) 0.82 (0.46, 1.45) 0.50 (0.31, 0.79)* 0.49 (0.32, 0.76)*
Diabetes 0.79 (0.32, 1.97) 0.81 (0.32, 2.00) 0.59 (0.27, 1.30) 0.63 (0.29, 1.35) 0.80 (0.46, 1.40) 0.80 (0.48, 1.33)
Influenza/pneumonia 0.61 (0.22, 1.70) 0.63 (0.23, 1.79) 0.45 (0.18, 1.13) 0.48 (0.19, 1.19) 0.68 (0.35, 1.33) 0.67 (0.35, 1.29)
gHypertension 1.51 (0.98, 2.34) 1.50 (0.97, 2.31) 1.26 (0.88, 1.80) 1.35 (0.95, 1.91) 1.15 (0.89, 1.49)
gArthritis 1.74 (1.09, 2.76)* 1.72 (1.08, 2.72)* 1.13 (0.77, 1.65)
gAsthma 1.99 (1.11, 3.58)* 2.00 (1.13, 3.53)* 1.30 (0.89, 1.49) 1.38 (0.94, 2.02)
Cardiovascular disease
gFalls experienced in the
previous 12 months
1.09 (0.89, 1.50) 1.14 (0.87, 1.49) 1.21 (0.94, 1.55)
Physical functioning 0.99 (0.99, 1.00) 1.00 (1.00, 1.00)
aThe cut point for acute level LOS was ≤5.8 days. Women with a maximum LOS of ≤5.8 days in their last year of life were compared with women who add no
hospitalisations. A total of 223 (56.3 %) of this sample experienced an acute level LOS
bHosmer-Lemeshow goodness of fit p value for the original model was 0.78 and 0.48 for the final model
cThe cut points for a medium level LOS was >5.8 days and ≤11.9 days. Women with a maximum LOS was >5.8 days and ≤11.9 days in their last year of life were
compared with women included in the acute level LOS analysis (i.e. those who had a maximum stay of ≤5.8 days (acute) or no hospitalisation). A total of 248
(38.5 %) of women of this sample experienced a medium level LOS
dHosmer-Lemeshow goodness of fit p value for the original model was 0.14 and 0.51 for the final model
eThe cut point for a palliative level LOS was >11.9 days. Women with a maximum LOS in their final year of life of >11.9 days were compared with women
included in the medium LOS analysis (i.e. those who had a maximum LOS of >5.8 days and ≤11.9 days (medium), >0 and ≤5.8 days (acute) and no
hospitalisation). A total of 561 (46.6 %) of women of this sample experienced a palliative level LOS
fHosmer-Lemshow goodness of fit p value for the original model was 0.08 and 0.07 for the final model
gNo is the reference category
hOnly included in the medium and palliative LOS models
iOnly included in the palliative LOS model
*Statistically significant (P <0.05)
Harris et al. BMC Health Services Research  (2016) 16:484 Page 7 of 12
acute hospitalisations and COD. Importantly, a two-fold
increase in risk of having a medium level LOS was noted
for women with asthma (95 % CI:1.13,3.53) compared to
those without the condition, while a 3–4-fold increase in
risk was found for those who died in hospital (OR = 4.16,
95CI:2.87,6.02) or were discharged to a nursing home
(OR = 3.07, 95 % CI:1.57,6.00) compared to women
who were discharged to home. Compared to women
who died of cancer, a 47 % (95%CI:0.33,0.86) decrease
in risk of a medium level LOS was noted for those
who died of ‘other’ causes. Similarly, mode of separ-
ation, number of medium level hospitalisations and
COD were associated with a palliative level LOS.
Discussion
Although examination of hospital use among older adults
has been a key focus due to its relevance to policy and fu-
ture healthcare planning, hospitalisation during the end of
life period has received less attention, with much of the
focus on healthcare expenditure [31, 32]. Using 12 years
of nationally representative data we were able to demon-
strate that for older women [33], hospital use in the last
year of life is complex and differs according to COD.
Women who died of organ failure spent the longest time
in hospital over the observation period, while women with
cancer had the highest median LOS. Longer lengths of
stay (medium and palliative levels) were found to be
primarily driven by mode of separation and number of
shorter-term admissions. The findings of this study have
important implications for healthcare pathways at the end
of life, including improving the access to, and integration
of, palliative, in home, and hospice services for life-limiting
conditions other than cancer.
In this study, the majority of women (85 %) were hospi-
talised at least once during the observation period. This
figure is slightly lower than that found in a recent 11-
month Australian state-based study [11]. While not
directly comparable, the findings are supported by other
studies with similar healthcare systems who found that
60–79 % of older adults were admitted to hospital at least
once in the last 6 months of life [9, 34]. Here, we were also
able to show the compression of hospital use over the last
year of life for six specific causes of death. Women who
died of cancer had a median LOS of 23 days, with half
admitted to hospital at least once within 5–12 months
prior to death. Women who died of dementia/Alzheimer’s
disease had a median LOS of 10 days and were admitted
to hospital much closer to death. Although previous
research has examined LOS of decedents over a 6 month
period [18] or dichotomized diagnostic groups as ‘cancer
vs non-cancer’ [11], the finding from our study is novel
with LOS shown to be highly dependent on COD.
Glaser and colleagues first developed the concept of
differing trajectories of dying, based on length and slope
of functional decline [35]. Lunney et al. [19] analyzed
these end of life trajectories for people with cancer, organ
failure (congestive heart failure or chronic lung disease),
and probable dementia (i.e. frailty) as well as those experi-
encing sudden death. Our findings, (extending this
research in terms of hospital use and COD), are consistent
with Lunney et al.’s regarding the trajectory for dementia.
For this group of women, number of hospitalisations
slowly increased across time and cumulative median LOS
increased with proximity to death. Among women dying
of cancer (when focused on hospital use), our findings
contrast with the pattern of functional decline described
by Lunney and colleagues [19], where these decedents
maintain high levels of function until the last few months.
Our data show that hospital use follows a more extended
pattern over the final 12 months of life with a majority of
women admitted 6–12 months prior to death, although
we did see a large increase in admissions in the last
2 months. Our findings mirror that of Lunney and col-
leagues regarding organ failure, with hospital admissions
extended over the 12 months and the primary reason for
admission being chronic obstructive airway disorders. Our
findings also show that in terms of median cumulative
LOS, women who died of diabetes had similar patterns of
hospitalisation as those who died of organ failure (particu-
larly within the last 3 months of life). In the last month
prior to death, more than half of women who died of ei-
ther diabetes or organ failure had multiple hospital admis-
sions. This is unsurprising given that heart failure is often
a complication of diabetes, particularly for women [36].
For women who died of diabetes, approximately half of
the reasons of admission in the last year were related to
cardiovascular disease.
Moreover, while 7.0 % of women in this very old cohort
died of diabetes, diabetes may become a more common
COD in successive cohorts as its age-specific prevalence
increases [37]. Diabetes management is therefore a health
care priority, with self-management a key component of
diabetes control [38, 39]. Best practice guidelines are pri-
marily based on research involving adults aged ≤75 years
[40] and have a strong emphasis on patient capacities to
engage in self-management practices [41–43]. Yet, it is un-
known how adults aged over 75 are able to self-manage
diabetes in the community, particularly when they enter
the final stages of life. Munshi et al. [44] found that barriers
to self-care in older adults with poorly controlled diabetes
related to a reluctance to make appropriate changes in in-
sulin doses between clinic visits or during illness. The im-
pact of intercurrent illness on the management of diabetes
is particularly important, with effects on glucose metabol-
ism through dysregulation of the hypothalamic-pituitary-
adrenal and sympathetic-adrenal-medullary axes [45].
In our study, 17 % of women who died of diabetes had
multiple hospital admissions within 6 months of death (and
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40 % had multiple admissions within 2 months of death). It
has been found that all-cause hospitalisation among adults
with diabetes increased with insulin use, age, presence of
chronic renal insufficiency, diagnosed hypoglycemia and a
diabetes-related hospitalisation in the year prior [46].
Integrated healthcare pathways across the disease
course and individualised care plans may assist in redu-
cing unnecessary (and potentially unwanted) hospitalisa-
tions at the end of life. General practitioners are at the
coal face of healthcare provision in Australia and may
play an important role in not only coordinating and
monitoring of care but also assisting with advanced care
planning. Abarashi et al. [47] found that there was a par-
ticular need in primary care for integrated palliative care
with optimal disease management for those with organ
failure and that initiation of advanced care planning
early in the chronic disease trajectory was imperative to
enable patients to live as well as possible with progres-
sive illness and die in line with their own preferences.
Although further research is required among this age
group, integrated community health care approaches
have been shown to improve the care of those with
diabetes (including a reduction in hospital admissions)
and other chronic conditions [48, 49], while hospital in
the home schemes have been suggested as one strategy
to effectively manage respiratory exacerbations through
either supported discharge after hospital admission or
admission avoidance [50].
We also examined factors associated with a medium and
palliative LOS (consistent with a LOS expected for palliative
conditions whether or not the admissions were classified as
palliative care). In contrast to De Korte-Verhoef et al. [13],
women who died of cancer were most likely to have a pal-
liative level LOS compared to other causes of death. The
number of other medium level lengths of stay were associ-
ated with a 27 % increased risk of experiencing a palliative
LOS while women who died in hospital or a nursing home
were up to four times more likely to be admitted to hospital
for a palliative LOS. Although the greatest proportion re-
lated to non-cancer diagnoses, a recent Western Australia-
based study found that almost two-thirds of patients were
in hospital in their final day of life (65 % of which were
women) [11]. Interestingly, a small proportion of women
did not have a hospitalisation at the end of life, with these
women more likely to die of ‘other’ causes and have private
health insurance. Whether this reflects issues surrounding
access and equity to health services (including primary
care) would require further exploration.
Taken together, the findings suggest that the Australian
health system may have an inability to recognise and
effectively manage end of life care [51]. Alternatively,
health professionals may make conscience decisions to
admit patients to acute care for long periods due to lack
of access to appropriate palliative care and hospice
services in community settings. Both state and federal
governments in Australia have made a commitment to
providing coordinated and consistent delivery of palliative
care through the National Palliative Care Strategy
(although mostly focused on cancer) [52]. The findings
from this study indicate that improved access to, and
knowledge of, palliative care services is required for older
women who die of not only cancer but other life-limiting
conditions. In our study, 49 % of women who died of
organ failure and 55 % of women who died of cancer were
admitted for a palliative LOS. It therefore begs the ques-
tion: is the acute care setting the best place to administer
end of life care for older women with these conditions?
Can we do better to contribute to these women having a
‘good death’? The answers to these questions are
extremely complex and require a shift in the collective
consciousness about how we talk about death and dying
and the importance of not interfering with the dying
process with the instigation of futile treatments [53].
Importantly, studies suggest that hospitalisation at the
end of life is often perceived as undesirable and can be as-
sociated with poorer outcomes for the patient and family
[54–56]. It has been shown that up to 60 % of older adults
die while in hospital [57]. This is despite research suggest-
ing that the majority of people express a wish to die at
home [58]. In our study, death in hospital ranged from
30 % (for dementia) to 59 % (for cancer and organ failure).
A Swiss study found that age, female gender, multimorbid-
ity and geographic location played a significant role in
place of death for older patients [34], while a Dutch study
examining the last 3 months of life found that people who
received informal home care were more likely to die in
hospital compared to institutional care [59]. It is argued
that older adults who are in institutionalised care may
have fewer transfers to hospital as they are already present
in a ‘medicalised’ environment and therefore are having
their needs met regarding treatment [47, 60]. This notion
is also supported in countries with differing healthcare
structures, such as the United States [21]. In our study
however, 24 % of women with dementia experienced a
medium level LOS and 35 % experienced a palliative LOS
in their last year of life. Additionally, discharge to a nurs-
ing home was associated with a three-to-four fold increase
in having an extended LOS.
It must be noted that although the majority of people
express a wish to die at home, Gott et al. [61] found that
this perception changed as death approached. As such,
while death at home may be perceived as optimal, in ac-
tuality this may not be achievable. With the concept of
‘home’ a malleable concept within the end of life context
[62], institutionalised forms of ‘home’ (i.e. hospice) may
provide the best of both worlds. However, more research
is required into the appropriateness and efficacy of such
programs [63].
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This study has a number of strengths including the
longitudinal nature of the data, with older women being
followed over a 12 year period. We were also able to link
nationally representative self-report data to a large ad-
ministrative dataset (involving both public and private
hospitals) and the NDI in order to describe patterns of
hospitalisation according to a number of causes of death
for a community sample of women aged in their 70s
through to their 80s. The study however has some limi-
tations. Firstly, we classified women according to their
primary COD. Comorbidities are common among older
adults and potentially impacts on health service use and
death trajectory. It is also important to acknowledge that
patterns of hospital use at the end of life may have chan-
ged over the course of the observation period, including
structural changes within the health care system as well
as changes to health care provision as a result of im-
proved technologies and new medications. Additionally,
the self-report measures were taken from the last com-
pleted survey prior to death and as such considerable
variability in the timing of measures may exist. However,
we adjusted for this variation in the analyses. Also, al-
though we examined palliative levels of LOS, we were
unable to determine the type of care the participants
were receiving (i.e. palliative or active life sustaining
treatment). We also did not have information on other
factors such as patient care preferences that may have
also impacted on LOS. Further, this study focused solely
on women. A Finnish study found significant differences
in patterns of hospitalisation for men compared to
women, with men having short lengths of stay [64].
Therefore, patterns of hospital use and predictors of
hospital use in the last year of life may be markedly dif-
ferent for men.
Conclusion
With global life expectancies increasing, effective planning
of health services for future generations will require high
quality information to understand how we may best
provide appropriate care at the end of life. We were able
to demonstrate the incremental increase in hospital use in
the last 12 months of life, with different patterns of
hospital use across six specific causes of death among
older women. The solution to reducing acute care admis-
sions at the end of life is extremely complex and requires
a shift in perception regarding end of life care and chronic
disease management.
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